ALFA Filings
Every announcement, straight from the exchange
Every Hexagon Nutrition earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Hexagon Nutrition delivered strong Q1 FY27 results with 43.2% revenue growth and 25.1% PAT growth. Management focused on expanding the branded portfolio and optimizing capacity utilization.
Hexagon Nutrition reported Q1 FY27 revenue of ₹1,043 Mn with 11.3% EBITDA margin. The firm focuses on specialized clinical and wellness nutrition brands like Pentasure and Pediagold.
Hexagon Nutrition reported strong FY26 performance with 17.8% revenue growth to ₹382.63 Cr and PAT surge of 56.1%. Focus remains on high-margin branded products and export expansion.
Hexagon Nutrition reported FY26 revenue of ₹3,826 Mn with 13.82% EBITDA margin. The company is transitioning to a listed B2C-focused player following its June 2026 IPO.